American Riviera
You are here:  Home  >  Biotech  >  Current Article

Judge overturns verdict upholding Repatha patents

By   /   Thursday, August 29th, 2019  /   Comments Off on Judge overturns verdict upholding Repatha patents

    Print       Email
A U.S. District Court judge overturned a jury verdict Aug. 28 that upheld several Amgen patents for its cholesterol reducing drug Repatha. The court found that Thousand Oaks-based Amgen’s patents did not adequately describe the product, called a PCSK9 inhibitor, which is an antibody that binds to an enzyme to reduce a particular kind of…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Our View: It’s time to take retail crime seriously

Read More →